TVGN
Tevogen Bio Holdings·NASDAQ
--
--(--)
--
--(--)
TVGN fundamentals
During Q4 2025, Tevogen Bio Holdings (TVGN) reported revenue of --, a YoY change of 0.00%. Net income was -4.68M, a YoY change of 50.47%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 115 -- | 170.01K -- | 282.88K -- | 258.58K -- | 198.83K +172797.39% | 212.79K +25.16% | 2.32M +721.65% | 2.18M +744.78% | 2.33M +1069.33% | 2.01M +844.26% | 29.52M +1169.93% | 8.60M +293.64% | 6.09M +161.74% | 9.36M +366.00% | 10.36M -64.91% | 5.44M -36.68% | 5.73M -5.85% | 4.61M -50.76% | 26.14M -- |
Selling, General and Administrative Expenses | 115 -- | 170.01K -- | 282.88K -- | 258.58K -- | 198.83K +172797.39% | 212.79K +25.16% | 977.11K +245.42% | 1.15M +345.92% | 1.21M +507.60% | 1.10M +417.52% | 8.71M +790.91% | 4.47M +288.06% | 2.82M +133.80% | 6.53M +492.70% | 7.16M -17.74% | 2.74M -38.66% | 2.62M -7.29% | 2.50M -61.63% | 15.03M -- |
General and Administrative Expenses | -- -- | 181.42K -- | -- -- | -- -- | -- -- | 953.08K +425.34% | -- -- | -- -- | 1.21M -- | 1.10M +15.54% | 8.71M -- | 4.47M -- | 2.82M +133.80% | 6.53M +492.70% | 7.16M -17.74% | 2.74M -38.66% | 2.62M -7.29% | 2.50M -61.63% | 15.03M -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.35M -- | 1.03M -- | 1.12M -- | 908.05K -- | 20.81M +1444.83% | 4.12M +299.89% | 3.26M +191.96% | 2.84M +212.35% | 3.20M -84.65% | 2.70M -34.54% | 3.11M -4.61% | 2.11M -25.76% | 11.11M -- |
Operating Income | -115 -- | -170.01K -- | -282.88K -- | -258.58K -- | -198.83K -172797.39% | -212.79K -25.16% | -2.32M -721.65% | -2.18M -744.78% | -2.33M -1069.33% | -2.01M -844.26% | -29.52M -1169.93% | -8.60M -293.64% | -6.09M -161.74% | -9.36M -366.00% | -10.36M +64.91% | -5.44M +36.68% | -5.73M +5.85% | -4.61M +50.76% | -26.14M -- |
Non-Operating Income (Loss) | -- -- | 152.68K -- | 256.89K -- | 465.58K -- | 1.81M -- | 2.83M +1751.83% | -28.43M -11167.68% | -20.00M -4395.67% | -1.58M -187.21% | -1.62M -157.40% | 40.78M +243.44% | -1.06M +94.68% | 201.30K +112.74% | -81.34K +94.99% | -10.71K -100.03% | -59.44K +94.42% | 2.62K -98.70% | -67.38K +17.17% | -134.92K -- |
Gain (Loss) on Other Investment | -- -- | 15.81K -- | -- -- | -- -- | -- -- | 4.95M +31205.80% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | 137.75K -- | -- -- | -- -- | -- -- | 413.25K +200.00% | -- -- | -- -- | -1.28M -- | -1.31M -415.90% | 48.44M -- | -174.43K -- | 213.76K +116.70% | -65.54K +94.98% | 13.86K -99.97% | -21.41K +87.73% | 64.96K -69.61% | 3.29K +105.03% | 60.70K -- |
Other Non-Operating Income (Loss) | -- -- | -880 -- | 256.89K -- | 465.58K -- | 1.81M -- | -2.53M -287873.86% | -28.14M -11055.18% | -19.70M -4331.25% | 0 -100.00% | 0 +100.00% | -7.50M +73.35% | -890.00K +95.48% | -- -- | 0 -- | 0 +100.00% | 0 +100.00% | -- -- | 0 -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 289.00K -- | 299.89K -- | 299.94K -- | 317.52K -- | 155.79K -46.09% | -6 -100.00% | 12.46K -95.85% | 15.80K -95.02% | 24.57K -84.23% | 38.03K +633983.33% | 62.34K +400.36% | 70.67K +347.36% | 195.62K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -115 -- | -17.33K -- | -25.99K -- | 207.00K -- | 1.61M +1402590.43% | 2.61M +15185.61% | -30.76M -118247.48% | -22.18M -10817.18% | -3.90M -342.11% | -3.63M -238.93% | 11.26M +136.63% | -9.66M +56.44% | -5.88M -50.69% | -9.44M -160.02% | -10.37M -192.03% | -5.50M +43.04% | -5.73M +2.68% | -4.68M +50.47% | -26.28M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -115 -- | -17.33K -- | -25.99K -- | 207.00K -- | 1.61M +1402590.43% | 2.61M +15185.61% | -30.76M -118247.48% | -22.18M -10817.18% | -3.90M -342.11% | -3.63M -238.93% | 11.26M +136.63% | -9.66M +56.44% | -5.88M -50.69% | -9.44M -160.02% | -10.37M -192.03% | -5.50M +43.04% | -5.73M +2.68% | -4.68M +50.47% | -26.28M -- |
Net Income Attributable to Owners of the Company | -115 -- | -17.33K -- | -25.99K -- | 207.00K -- | 1.61M +1402590.43% | 2.61M +15185.61% | -30.76M -118247.48% | -22.18M -10817.18% | -3.90M -342.11% | -3.63M -238.93% | 11.26M +136.63% | -9.66M +56.44% | -5.88M -50.69% | -9.44M -160.02% | -10.37M -192.03% | -5.50M +43.04% | -5.73M +2.68% | -4.68M +50.47% | -26.28M -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 24.93K -- | 25.20K -- | -51.51K -- | -- -- | 137.12K +449.99% | 135.62K +438.05% | -409.86K -695.76% | -- -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.61M -- | 0 -- | 3.47M -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -115 -- | -17.33K -- | -25.99K -- | 207.00K -- | 1.61M +1402590.43% | 2.61M +15185.61% | -30.76M -118247.48% | -22.18M -10817.18% | -3.90M -342.11% | -3.63M -238.93% | 11.26M +136.63% | -6.08M +72.61% | -5.91M -51.33% | -12.86M -254.13% | -10.37M -192.03% | -5.64M +7.15% | -5.86M +0.80% | -4.27M +66.82% | -26.14M -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -13.73M -- | -- -- | -- -- | -- -- | -26.28M -91.41% | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -28.75K -- | -- -- | -- -- | -- -- | 4.41M +15436.10% | -- -- | -- -- | -3.90M -- | -3.63M -182.39% | 11.26M -- | -9.66M -- | -- -- | -13.73M -277.93% | -10.37M -192.03% | -5.50M +43.04% | -- -- | -26.28M -91.41% | -- -- |
Basic EPS | -- -- | -- -- | 0 -- | 0 -- | 0.03 -- | 0.05 -- | -0.26 -- | -0.18 -- | -0.03 -200.00% | -0.24 -580.00% | 0.08 +130.77% | -0.04 +77.78% | -0.03 -- | -0.07 +70.83% | -0.07 -187.50% | -0.03 +25.00% | -0.03 -- | -0.02 +71.43% | -0.15 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.03 -- | -- -- | 0.08 -- | -0.04 -- | -0.03 -- | -- -- | -0.07 -187.50% | -0.03 +25.00% | -0.03 -- | -- -- | -- -- |
Diluted EPS | -- -- | -- -- | 0 -- | 0 -- | 0.03 -- | -- -- | -0.26 -- | -0.18 -- | -0.03 -200.00% | -- -- | -0.26 -- | -0.04 +77.78% | -0.03 -- | -- -- | -0.07 +73.08% | -0.03 +25.00% | -0.03 -- | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.03 -- | -- -- | -0.26 -- | -0.04 -- | -0.03 -- | -- -- | -0.07 +73.08% | -0.03 +25.00% | -0.03 -- | -- -- | -- -- |
You can ask Aime
What factors drove the changes in Tevogen Bio Holdings's revenue and profit?What does Tevogen Bio Holdings do and what are its main business segments?What were the key takeaways from Tevogen Bio Holdings’s earnings call?What were the key takeaways from Tevogen Bio Holdings's earnings call?Did Tevogen Bio Holdings beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Tevogen Bio Holdings year over year?What guidance did Tevogen Bio Holdings's management provide for the next earnings period?What is the market's earnings forecast for Tevogen Bio Holdings next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
